PMA device
Genio® System 2.1
Nyxoah S.A. · Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ, Class III) · First FDA decision Aug 8, 2025, newest Nov 6, 2025Sleep apnea
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
7
Naming "Genio"
MAUDE reports
38
Brand "Genio", since 2015
PubMed studies
26
Mentioning "Genio"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Genio® System 2.1
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- Genio® System 2.1PMA supplement
P240024-S002 · Decided Nov 6, 2025 · 62 days after receipt · Normal 180 Day Track No User Fee
Device type: Stimulator, hypoglossal nerve, implanted, apnea (MNQ) · Anesthesiology & Respiratory
- Genio® System 2.1PMA supplement
P240024-S001 · Decided Oct 3, 2025 · 28 days after receipt · Normal 180 Day Track No User Fee
Device type: Stimulator, hypoglossal nerve, implanted, apnea (MNQ) · Anesthesiology & Respiratory
P240024 · Decided Aug 8, 2025 · 403 days after receipt
Device type: Stimulator, hypoglossal nerve, implanted, apnea (MNQ) · Anesthesiology & Respiratory
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38387Wellpoint FederalUpdated Jul 14, 2026
- Hypoglossal Nerve Stimulation for Obstructive Sleep ApneaLocal determinationIn effectL38276Palmetto GBAUpdated May 8, 2026
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38528WPS Insurance CorporationUpdated Mar 20, 2026
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38307CGS Administrators, LLCUpdated Feb 27, 2026
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38310Noridian Healthcare Solutions, LLCUpdated Oct 16, 2025
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38398First Coast Service Options, Inc.Updated Jan 24, 2020
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38385Novitas Solutions, Inc.Updated Jan 24, 2020
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Genio", any status and sponsor, newest update first.
Nyxoah Inc.Not on our public-company list
NCT07331285 · 229 participants (planned) · Start Jun 2026 · Primary completion Oct 2028
Device: This is a single arm study, all consented and eligible subjects will be implanted with the Genio® System 2.1 · For: Obstructive Sleep Apnea
Sites: Miami, Florida; Summit, New Jersey
- Dual-sided Hypoglossal neRvE stimulAtion for the treatMent of Obstructive Sleep Apnea (DREAM)Active, not recruiting
Nyxoah S.A.Not on our public-company list
NCT03868618 · 115 participants (planned) · Start Oct 14, 2020 · Primary completion Feb 20, 2024
Device: Genio™ system · For: Obstructive Sleep Apnea
Sites: Birmingham, Alabama; Boca Raton, Florida; Tampa, Florida · 21 sites in all
- A Post-market Clinical Follow up of the Genio® System for the Treatment of Obstructive Sleep Apnea in AdultsActive, not recruiting
Nyxoah S.A.Not on our public-company list
NCT04031040 · 110 participants (planned) · Start Sep 1, 2019 · Primary completion Oct 30, 2026
Device: Genio® system therapy · For: Obstructive Sleep Apnea
Sites: Antwerp, Belgium; Angers, France; Créteil, France · 19 sites in all
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Genio", and for the whole product code for context.
This brand
38 reports: 0 malfunction, 38 injury, 0 death
Whole product code MNQ
3,753 reports: 165 malfunction, 3,581 injury, 4 death
Newest reports for this brand
- Genio ISInjury
3030384402-2026-00006 · Received Oct 29, 2026 · Event dated Sep 29, 2026
Device type: Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Dehydration; Neuralgia
- Genio ISInjury
3030384402-2026-00007 · Received Oct 29, 2026 · Event dated Oct 5, 2026
Device type: Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ)
Device problem as coded: Failure to Deliver Energy
Patient problem as coded: Inappropriate Device Stimulation of Tissue
- Genio ISInjury
3017191859-2026-00031 · Received Oct 28, 2026 · Event dated Oct 16, 2026
Device type: Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ)
Device problem as coded: Failure to Deliver Energy; Malposition of Device
Patient problem as coded: Unspecified Tissue Injury; Inappropriate Device Stimulation of Tissue
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Genio"[tiab]. The summary above synthesizes these.
- Geniohyoid muscle function in awake canines.
Yokoba M, Hawes HG, Easton PA · J Appl Physiol (1985) · 2003Research Support, Non-U.S. Gov't
- Recovery of neurosensory function following orthognathic surgery.
Karas ND, Boyd SB, Sinn DP · J Oral Maxillofac Surg · 1990
- Breathing during sleep.
Flenley DC · Ann Acad Med Singap · 1985Review
- Genio-molar anchorage.
Bchd JD · J Clin Orthod · 1981Case Reports
- Head posture impacts mammalian hyoid position and suprahyoid muscle length: implication for swallowing biomechanics.
Li P, Ross CF, Luo ZX, et al. · Philos Trans R Soc Lond B Biol Sci · 2023Research Support, Non-U.S. Gov't
- [Anatomical study of the human lingual muscle. Myofibrous organization of the extrinsic muscles].
Ohgaki A, Sato T · Shigaku · 1989English Abstract
- Rational Design Assisted by Evolutionary Engineering Allows (De)Construction and Optimization of Complex Phenotypes in Pseudomonas putida KT2440.
Blázquez B, Nogales J · Microb Biotechnol · 2025
- GenIO: a phenotype-genotype analysis web server for clinical genomics of rare diseases.
Koile D, Cordoba M, de Sousa Serro M, et al. · BMC Bioinformatics · 2018Research Support, Non-U.S. Gov't
- Bilateral hypoglossal nerve stimulation for treatment of adult obstructive sleep apnoea.
Eastwood PR, Barnes M, MacKay SG, et al. · Eur Respir J · 2020Research Support, Non-U.S. Gov't
- Bilateral vs Unilateral Hypoglossal Nerve Stimulation in Patients With Obstructive Sleep Apnea.
Heiser C, Sommer JU, Hofauer B, et al. · OTO Open · 2022
- Managing Complete Concentric Collapse in Obstructive Sleep Apnea: A Narrative Review.
Sorenson KR, Fish A, Brooks BD · Cureus · 2025Review
- Narrow range of early habitable Venus scenarios permitted by modeling of oxygen loss and radiogenic argon degassing.
Warren AO, Kite ES · Proc Natl Acad Sci U S A · 2023
Other devices of this type
Also filed under product code MNQ.
- Inspire II Upper Airway StimulatorInspire Medical Systems · PMA 2026
- Inspire® Upper Airway StimulationInspire Medical Systems · PMA 2025
- aura6000 systemLivaNova USA, Inc. · PMA 2026
- Inspire UAS High AHI/High BMIInspire Medical Systems · PMA 2023
- SleepSync ProgrammerInspire Medical Systems · PMA 2023
- Silicone Stimulation Lead, Silicone Sensing LeadInspire Medical Systems · PMA 2022
- Inspire Medical Systems, Model 2580 Patient ProgrammerInspire Medical Systems · PMA 2021
- Inspire Programmer SystemInspire Medical Systems · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.